Usage, acceptability, and preliminary effectiveness of an
mHealth-based integrated modality for smoking cessation
interventions in Western China

Shuilian Chu; Zhaohui Tong; Yuntao Zhang; Xianwei Ye; Zhiyan Liu; Hong Chen; Jing Bai; Fengsen Li; Xiaoping Li; Huaizhen Wang; Rui Wang; Xuefeng Wang; Jiachen Li; Siqiao Liang; Ying Nong; Xin Wang; Ahong Wang; Di Zhang; Hang Jing; Lin Feng; Lirong Liang

doi:10.18332/tid/156828

Tobacco Induced Diseases (Jan 2023)

Usage, acceptability, and preliminary effectiveness of an mHealth-based integrated modality for smoking cessation interventions in Western China

Shuilian Chu,
Zhaohui Tong,
Yuntao Zhang,
Xianwei Ye,
Zhiyan Liu,
Hong Chen,
Jing Bai,
Fengsen Li,
Xiaoping Li,
Huaizhen Wang,
Rui Wang,
Xuefeng Wang,
Jiachen Li,
Siqiao Liang,
Ying Nong,
Xin Wang,
Ahong Wang,
Di Zhang,
Hang Jing,
Lin Feng,
Lirong Liang

Affiliations

Shuilian Chu: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Zhaohui Tong: Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Yuntao Zhang: Department of Respiratory Medicine, People’s Hospital of Lhasa Tibet, Lhasa, Tibet Autonomous Region, China
Xianwei Ye: ORCiD; Department of Pulmonary and Critical Care Medicine, Guizhou Provincial People’s Hospital, Guiyang, China
Zhiyan Liu: ORCiD; Department of Respiratory and Critical Care Medicine, Xi'an Third Hospital, Xi'an, China
Hong Chen: ORCiD; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China
Jing Bai: ORCiD; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Fengsen Li: ORCiD; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, China
Xiaoping Li: ORCiD; Department of Respiratory and Critical Care Medicine, The First People’s Hospital of Zunyi, Zunyi, China
Huaizhen Wang: ORCiD; Hospital Management Office, Kashgar Prefecture Second People’s Hospital, Kashgar, China
Rui Wang: ORCiD; Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Xuefeng Wang: ORCiD; Department of Respiratory and Critical Care Medicine, Xining Second People’s Hospital, Xining, China
Jiachen Li: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Siqiao Liang: ORCiD; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Ying Nong: ORCiD; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, China
Xin Wang: ORCiD; Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Traditional Chinese Medicine, Xinjiang Medical University, Urumqi, China
Ahong Wang: ORCiD; Department of Respiratory and Critical Care Medicine, Kashgar Prefecture Second People’s Hospital, Kashgar, China
Di Zhang: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Hang Jing: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Lin Feng: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
Lirong Liang: ORCiD; Department of Research on Tobacco Dependence Therapies, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China

DOI: https://doi.org/10.18332/tid/156828
Journal volume & issue: Vol. 21, no. January
pp. 1 – 13

Abstract

Read online

Introduction Many smokers have not accessed professional smoking cessation assistance due to limited smoking cessation services. We developed a novel mHealth-based integrated modality for smoking cessation (WeChat + Quitline modality, WQ modality) and applied it to a large public welfare project (China Western-QUIT Program) in western China. This study evaluated the usage, acceptability, and preliminary effectiveness of the WQ modality in the population of western China. Methods A prospective cohort study was conducted between April and August 2021. Smokers or their relatives were recruited through online advertisements and medical staff referrals. After using the services of the WQ modality for one month, the self-reported awareness, use, and satisfaction with each service among the participants were collected by a telephone interview. We also evaluated the self-reported 7-day point prevalence of abstinence (PPA) and quit attempt rate among baseline current smokers. The usage data of each service were downloaded from quitline and WeChat platforms. Results Of the 17326 people from western China using the WQ modality, the largest number of users was WeChat official account (11173), followed by WeChat mini program (3734), WeChat group (669), and quitline (541 inbound calls, 605 outbound calls). At one month follow-up, over 70% of participants who completed the baseline survey (n=2221) were aware of WeChat-based services, and over 50% used them. However, the awareness rate (11.1%) and utilization rate (0.5%) of quitline were relatively low. The median satisfaction scores across all services were 9 out of 10 points (IQR: 8–9). Among the baseline current smokers (n=1257), self-reported 7-day PPA was 41.8% (526/1257), and another 225 smokers (17.9%) reported making a quit attempt. Conclusions The WQ modality could be well used and accepted, and it has great potential to motivate and aid short-term smoking cessation in smokers from western China.

Published in Tobacco Induced Diseases

ISSN: 1617-9625 (Online)
Publisher: European Publishing
Country of publisher: Greece
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://www.tobaccoinduceddiseases.org

About the journal

Abstract

Keywords